SEC Tracker
Get the app

Lisata Therapeutics LSTA

Lisata Therapeutics approved 2026 equity plans

Lisata Therapeutics (LSTA) filed an 8-K with the SEC on Nov 9, 2026, 5:15 pm ET. Source: the filing on SEC EDGAR.

Item 5.02 Executive or director change, Item 5.07 Shareholder vote results, Item 8.01 Other events

Form
8-K
Filed
Importance
Major
  1. 2026 Equity Incentive Plan has 44,764,472 shares reserved
  2. 2026 ESPP has 3,730,372 shares reserved
  3. Stockholders approved 2026 Plan and ESPP at annual meeting

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Lisata Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.